Commonwealth legislation

National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2015 (No. 9) - specification under subsection 84AAA(2) (PB 103 of 2015)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

What this does:

This instrument adds the medicine Ponatinib to the list of pharmaceuticals that can be supplied early under the Pharmaceutical Benefits Scheme (PBS).

Why it matters:

Normally, PBS rules require patients to wait a set period between collecting repeat prescriptions. "Early supply" rules allow patients to get their next batch of medication before that waiting period ends—useful for travel or avoiding stock shortages. This amendment gives patients taking Ponatinib access to those flexible arrangements.

The specifics:

The update adds two tablet strengths to the early supply list:

15mg tablets – permitting early supply of up to 60 tablets
45mg tablets – permitting early supply of up to 30 tablets

The numbers set out exactly how much can be supplied and how often, ensuring the concession is used appropriately.

Who is affected:

Patients prescribed Ponatinib under the PBS, and the pharmacists who dispense it.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2015 (No. 9) - specification under subsection 84AAA(2) (PB 103 of 2015).

National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2015 (No. 9) - specification under subsection 84AAA(2) (PB 103 of 2015)

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2 title: Normal.dot

?xml version="1.0" encoding="utf-8" standalone="no"?>

View image in the official source

PB 103 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2)

National Health Act 1953

I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 23 October 2015

PAUL CREECH

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

Amendment determination – Pharmaceutical Benefits – Early Supply

1 Name of Instrument

(1) This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2).

(2) This Instrument may also be cited as PB 103 of 2015.

2 Commencement

This Instrument commences on 1 November 2015.

3 Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1 Amendments

[1] Schedule 1, after entry for Pindolol in the form Tablet 15 mg

insert:

Ponatinib Tablet 15 mg (as hydrochloride) Oral 60 5 60
Tablet 45 mg (as hydrochloride) Oral 30 5 30

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.